BioSyent is a profitable growth oriented specialty pharmaceutical company seeking out opportunities to in-license or acquire innovative pharmaceutical products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients and supporting the healthcare professionals that treat them. Once a product of interest has been found, BioSyent acquires the exclusive rights to the product and manages it through the Canadian governmental regulatory approval process. Upon approval, the company markets the product throughout Canada. For more information, visit the company’s website at www.biosyent.com.